BRILOVUS

Welcome to the Brand page for “BRILOVUS”, which is offered here for Pharmaceutical preparations for the treatment and prevention of brain and central nervous diseases and disorders; vaccines; pharmaceutical preparation and substances for the prevention and treatment of disorders and diseases in, generated from or affecting the brain and the central nervous system; pharmaceutical preparations and substances acting on the brain and central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological diseases and disorders; pharmaceutical preparations and substances for the prevention and treatment of alzheimer's disease and disorder, depression, mood disorder, psychosis, anxiety, epilepsy, sclerosis, porphyria, huntington's disease and disorder, insomnia, parkinson disease and disorder, schizophrenia, bipolar disease and disorder, oncology, pain, alcoholism and dependency; medical diagnostic preparations, substances, reagents and agents;.

Its status is currently believed to be active. Its class is unavailable. “BRILOVUS” is believed to be currently owned by “H. Lundbeck A/S”.